REFERENCES
- Viscoli C and the ICFCG EORTC Cooperative Group. Fun-gaemia in cancer patients in Europe. Abstracts, 3rd EC-CMID, Vienna 1–3.4. 1995, Abstract no. 133.
- Abi Said D, Annaissie E, Uzun O, Raad I, Pinczowski H, Vartivarian S. Epidemiology of Hematogenous Candidiasis. Clin Inf Dis 1997; 24: 1122–8.
- Wingard J. Importance of Candida spp. other than C. albi-cans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115–25.
- Wingard J. Increase in C. krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. Engl J Med 1991; 325: 1274–7.
- Wingard J, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saval R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemoth 1993; 37: 1847 —9.
- Krcmery V Jr, Kunova A. Trichosporon spp. fungemia in cancer patients. Acta Chem 1997; 8: 33–5.
- Palemblad P. Antifungal prophylaxis: more bacteremia? Int J Infect Dis 1997; 51: 95–9.
- White M. Epidemiology of invasive candidiasis. Int J Inf Dis 1997; 51: 7–10.
- Lecciones J, Lee LW, Navano EE, et al. Vascular catheter associated fungemia in patients with cancer. Clin Inf Dis 1992; 14: 875–83.